The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
O-Methyl-5-N-butanoyl-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosylonic Acid ID: ALA497015
PubChem CID: 44583527
Max Phase: Preclinical
Molecular Formula: C14H25NO9
Molecular Weight: 351.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)O[C@](OC)(C(=O)O)C[C@@H]1O
Standard InChI: InChI=1S/C14H25NO9/c1-3-4-9(19)15-10-7(17)5-14(23-2,13(21)22)24-12(10)11(20)8(18)6-16/h7-8,10-12,16-18,20H,3-6H2,1-2H3,(H,15,19)(H,21,22)/t7-,8+,10+,11+,12+,14-/m0/s1
Standard InChI Key: ZOLHANKVXPTAEF-KLKPRGAGSA-N
Molfile:
RDKit 2D
25 25 0 0 0 0 0 0 0 0999 V2000
-2.1504 -6.6664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4286 -7.0752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7176 -6.6569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7221 -5.8280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4439 -5.4191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1612 -5.8391 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1657 -5.0195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7361 -4.9954 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1827 -4.1960 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.8748 -5.4461 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0004 -7.0646 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4219 -7.9002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7042 -8.3067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6974 -9.1317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0069 -7.8884 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.8605 -7.0863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8706 -6.2637 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.5793 -6.6815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8517 -7.9113 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.5879 -5.8565 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.2893 -7.1014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0081 -6.6965 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0152 -5.3966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0203 -9.5384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0272 -10.3633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 6 1 0
12 13 1 0
13 14 1 0
5 7 1 0
13 15 2 0
1 2 1 0
1 16 1 0
5 8 1 1
1 17 1 1
1 6 1 0
16 18 1 0
2 3 1 0
16 19 1 6
7 9 1 0
18 20 1 1
7 10 2 0
18 21 1 0
3 4 1 0
21 22 1 0
3 11 1 6
8 23 1 0
4 5 1 0
14 24 1 0
2 12 1 1
24 25 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 351.35Molecular Weight (Monoisotopic): 351.1529AlogP: -2.44#Rotatable Bonds: 8Polar Surface Area: 165.78Molecular Species: ACIDHBA: 8HBD: 6#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 6#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.05CX Basic pKa: ┄CX LogP: -1.78CX LogD: -5.24Aromatic Rings: ┄Heavy Atoms: 24QED Weighted: 0.28Np Likeness Score: 1.03
References 1. Johansson S, Nilsson E, Qian W, Guilligay D, Crepin T, Cusack S, Arnberg N, Elofsson M.. (2009) Design, synthesis, and evaluation of N-acyl modified sialic acids as inhibitors of adenoviruses causing epidemic keratoconjunctivitis., 52 (12): [PMID:19456100 ] [10.1021/jm801609s ]